Pandemic influenza H1N1 vaccine (inactivated, adjuvanted, Sanofi Pasteur)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePandemic influenza H1N1 vaccine (inactivated, adjuvanted, Sanofi Pasteur)
Drug Alias Name大流行流感HIN1疫苗（赛诺菲）pandemic influenza vaccine (H1N1, split virion, inactivated, adjuvanted)split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A) *propagated in eggs.PanenzaHumenza
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2010/06/08
Country/TerritoryUnited StatesFranceBrazil +[5] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi Pasteur SaSanofi PasteurInstituto Butantan +[4] 
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ07BB02
Related LinksN/A